Chronic Obstructive Pulmonary Disease (COPD) is a significant cause of disability and morbidity in Australia and New Zealand. World COPD Day takes place this year on November 17th. This year’s message of “Healthy Lungs – Never More Important” focuses on the fact that the burden of COPD remains, despite the ongoing global COVID pandemic. Awareness campaigns like World COPD Day also serve to remind us of the vital role clinical research sites play in bringing these options closer to patients.
What Do You Look for in a Site?
Even in light of COVID, COPD remains a leading cause of death worldwide – there is never a more critical time to focus on lung health and supporting ongoing life-saving research. As we continue to learn more and develop potential new therapies for respiratory diseases like COPD, partnering with experienced, results-driven sites is at the top of every sponsor and CRO list.
Pacific Clinical Research Network has 16 clinical research facilities with 4 sites located throughout Australia and 12 throughout New Zealand. We have extensive experience in conducting respiratory trials as well as other primary health and specialty trials.
We Meet Enrollment Targets and Deliver Quality Data
Pacific Clinical Research Network has applied unique solutions to reduce start-up times, meet and exceed enrollment goals, maintain high-quality data, and reduce study costs for sponsors and CROs in an industry filled with roadblocks. Our confidence comes from our business model that includes:
- Centralized approach:
- One contract
- Centralized budget negotiations
- Network centralization
- Shared leadership, SOPs, and technology
- Access to a diverse range of clinical trial participants
- Efficient, intuitive, cutting-edge, and cloud-based CTMS featuring:
- Monitoring portal
16 Sites, 99,413 Total Patient Visits, 6,422 Total Randomized Patients, and Counting.
Don’t miss another enrollment target. Contact us today to learn more about the PCRN difference when you partner with us!